Literature DB >> 9462528

Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation.

J R Pawloski1, R V Swaminathan, J S Stamler.   

Abstract

BACKGROUND: Nitric oxide (NO) and related molecules are thought to inhibit human platelet aggregation by raising levels of cGMP. METHODS AND
RESULTS: Both oxidative stress (reactive oxygen species) and hemoglobin (Hb) seem to oppose NO effects. A major fraction of NO in the blood is bound to thiols of Hb, forming S-nitrosohemoglobin (SNO-Hb), which releases the NO group on deoxygenation in the microcirculation. Here we show that (1) both cell-free and intraerythrocytic SNO-Hb (SNO-RBC) inhibit platelet aggregation, (2) the oxidation state of the hemes in Hb influences the response--SNO-metHb (which is functionally similar to SNO-deoxyHb) has greater platelet inhibitory effects than SNO-oxyHb, and (3) the mechanism of platelet inhibition by SNO-Hb is cGMP independent.
CONCLUSIONS: We suggest that the RBC has evolved a means to counteract platelet activation in small vessels and the proaggregatory effects of oxidative stress by forming SNO-Hb.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462528     DOI: 10.1161/01.cir.97.3.263

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Evidence for in vivo transport of bioactive nitric oxide in human plasma.

Authors:  Tienush Rassaf; Michael Preik; Petra Kleinbongard; Thomas Lauer; Christian Heiss; Bodo-Eckehard Strauer; Martin Feelisch; Malte Kelm
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.

Authors:  I L Megson; N Sogo; F A Mazzei; A R Butler; J C Walton; D J Webb
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Effect of processing and storage on red blood cell function in vivo.

Authors:  Allan Doctor; Phil Spinella
Journal:  Semin Perinatol       Date:  2012-08       Impact factor: 3.300

Review 4.  Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin.

Authors:  Timothy J McMahon; Allan Doctor
Journal:  Proc Am Thorac Soc       Date:  2006-04

Review 5.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

Review 6.  S-nitrosylation in cardiovascular signaling.

Authors:  Brian Lima; Michael T Forrester; Douglas T Hess; Jonathan S Stamler
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

7.  Regulation of platelet granule exocytosis by S-nitrosylation.

Authors:  Craig N Morrell; Kenji Matsushita; Kelly Chiles; Robert B Scharpf; Munekazu Yamakuchi; Rebecca J A Mason; Wolfgang Bergmeier; Joseph L Mankowski; William M Baldwin; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

8.  Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.

Authors:  Jun-Yan Liu; Ning Li; Jun Yang; Nan Li; Hong Qiu; Ding Ai; Nipavan Chiamvimonvat; Yi Zhu; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

9.  Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme.

Authors:  F Omodeo-Salè; L Cortelezzi; Z Vommaro; D Scaccabarozzi; A M Dondorp
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-31       Impact factor: 4.249

10.  Surface properties and in vitro analyses of immobilized chitosan onto polypropylene non-woven fabric surface using antenna-coupling microwave plasma.

Authors:  Yu-Chang Tyan; Jiunn-Der Liao; Shu-Ping Lin
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.